imatinib

(redirected from Imatinib mesilate)
Also found in: Medical.

i·mat·i·nib

 (ĭ-măt′ə-nĭb)
n.
A tyrosine kinase inhibitor, C29H31N7O, used in its mesylate form to treat certain types of leukemia and various other diseases.
References in periodicals archive ?
this discount agreement for dasatinib products does not include the following patent protected indication areas: b) treatment of adult patients with newly diagnosed ph + chronic myeloid leukemia (cml) in the chronic phase; c) treating adult patients with cml in the chronic or accelerated phase or blast crisis with resistance or intolerance to prior treatment including imatinib mesilate; d) treatment of adult patients with lymphatic blast crisis of cml with resistance or intolerance to previous therapy; e) treatment of children and adolescents with newly diagnosed philadelphia chromosome positive (ph +) chronic myeloid leukemia (cml) in the chronic phase (ph + cml-cp) or ph + cml-cp with resistance or intolerance to previous therapy including imatinib.
After the tyrosine kinases were available, the treatment was changed with imatinib mesilate. He used imatinib mesilate irregularly and he was diagnosed as accelerated phase CML.
Several examples of pharmaceutically important compounds include trimethoprim, sulfadiazine, imatinib mesilate and capecitabine.